Article
Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
Mayo Clinic College of Medicine, Jacksonville, Florida, 32224, USA.
Journal of Neurocytology (impact factor:
1.94).
01/2006;
34(6):397-410.
DOI:10.1007/s11068-006-8726-0
pp.397-410
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Implantation of neural stem cells embedded in hyaluronic acid and collagen composite conduit promotes regeneration in a rabbit facial nerve injury model.
[show abstract] [hide abstract]
ABSTRACT: The implantation of neural stem cells (NSCs) in artificial scaffolds for peripheral nerve injuries draws much attention. NSCs were ex-vivo expanded in hyaluronic acid (HA)-collagen composite with neurotrophin-3, and BrdU-labeled NSCs conduit was implanted onto the ends of the transected facial nerve of rabbits. Electromyography demonstrated a progressive decrease of current threshold and increase of voltage amplitude in de-innervated rabbits after implantation for one, four, eight and 12 weeks compared to readouts derived from animals prior to nerve transection. The most remarkable improvement, observed using Electrophysiology, was of de-innervated rabbits implanted with NSCs conduit as opposed to de-innervated counterparts with and without the implantation of HA-collagen, NSCs and HA-collagen, and HA-collagen and neurotrophin-3. Histological examination displayed no nerve fiber in tissue sections of de-innervated rabbits. The arrangement and S-100 immunoreactivity of nerve fibers in the tissue sections of normal rabbits and injured rabbits after implantation of NSCs scaffold for 12 weeks were similar, whereas disorderly arranged minifascicles of various sizes were noted in the other three arms. BrdU+ cells were detected at 12 weeks post-implantation. Data suggested that NSCs embedded in HA-collagen biomaterial could facilitate re-innervations of damaged facial nerve and the artificial conduit of NSCs might offer a potential treatment modality to peripheral nerve injuries.Journal of Translational Medicine 12/2008; 6:67. · 3.41 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
2 months
6 months
abnormal accumulation
densely
extensive vacuolation
filamentous tau inclusions
immune deficiency syndrome
Luxol fast blue/periodic acid Schiff
myelin figures
myelin sheaths
myelinated axons
neuronal loss
previous axonal tubes
spinal motor neurons
swollen axons
thin myelin sheaths
toluidine blue stained sections
upstream neurons
vacuolar myelinopathy
vitamin B12 deficiency